Thus, membrane protein ADORA2A upregulation and activation reveal a new mechanism of NEtD in NEPC and SCLC via ERK/MYC/PYCR/SIRT6/7 axis and is a potential druggable target in NE carcinoma. Here, ADORA2A is linked to small cell lung carcinoma.